REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE

Clinical trials for REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE trials appear

Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Supercharged immune cells tested as new weapon against tough leukemia

Disease control Recruiting now

This early-stage study is testing a new version of CAR T-cell therapy for people whose acute lymphoblastic leukemia (ALL) has come back or hasn't responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target and fight the …

Matched conditions: REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE

Get alerted when new REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE trials appear

Supercharged immune cells tested as new weapon against tough leukemia